Siemens Healthineers Mini-Newsletter
Web version

 
   
 
 
 

Shaping the future of tomosynthesis in screening

 

With 50° wide-angle tomosynthesis. Superior by design.

 
At Siemens Healthineers, we believe that tomosynthesis will dominate the screening space in the near future. And we are convinced that 50° wide-angle tomosynthesis is the superior method for cancer detection1. It provides the highest mass detectability2, increasing your diagnostic accuracy. Not only do we enable superior cancer detection1 with our 50° wide-angle tomosynthesis, but we also deliver a patient-centric solution – with decreased compression and the right dose.

Get the proof here
 
 
 
Experts discuss the future of screening
Tomosynthesis was one of the hottest topics at the 9th Breast Care Day at ECR 2019. Leading breast care experts talked about future screening programs, personalized breast cancer screening, and strategies to bring tomosynthesis into screening.

Watch the recordings
Get the program here
 
Key clinical findings of 50° wide-angle tomosynthesis
Following its market introduction in 2009, numerous clinical studies on 50° wide-angle tomosynthesis have demonstrated its high clinical value and diagnostic accuracy for breast imaging. Get a summary of all key findings from studies conducted with 50° wide-angle tomosynthesis.

Download the bibliography
Download Malmö study
 
Will DBT replace FFDM?
A recent study published in the American Journal of Roentgenology showed that 50° wide-angle, two-view DBT alone provided a greater diagnostic accuracy than FFDM for most radiologists, even for those inexperienced with DBT technology. Reader performance for breast cancer detection was higher with 50° wide-angle DBT, providing convincing evidence for its robustness as a stand-alone method.

Access the study
Click here for more information
 
Contact Us | Privacy Policy
 
1 Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D et al. (2018) One-view breast tomosynthesis versus twoview mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): A prospective, population-based, diagnostic accuracy study. The Lancet Oncology. doi:10.1016/S1470-2045(18)30521-7.

2 David A. Scaduto, Hailiang Huang, Chunling Liu, Kim Rinaldi, Axel Hebecker, Thomas Mertelmeier, Sebastian Vogt, Paul Fisher, Wei Zhao, "Impact of angular range of digital breast tomosynthesis on mass detection in dense breasts," Proc. SPIE 10718, 14th International Workshop on Breast Imaging (IWBI 2018), 107181V (6 July 2018); doi: 10.1117/12.2318243

The products/features and/or service offerings (mentioned herein) are not commercially available in all countries and/or for all modalities. Their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
This email was sent by:
Siemens Healthcare GmbH | Henkestr. 127, 91052 Erlangen, Germany
siemens-healthineers.com
Information for healthcare professionals. The Siemens Healthineers newsletter and websites, including but not limited to siemens-healthineers.com and its affiliated sites, provide an online resource for healthcare professionals
 
 
 
 Do not reply to this email as it was sent from an unmonitored account.
  
Unsubscribe from the Breaking News.
  
Reset your password.
  
Contact auntminnieeurope.com support.
  
AuntMinnieEurope.com Privacy Policy
  
Email sent to: .
 

AuntMinnieEurope.com, 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA
+1 520-298-1000